Article

New Type 1 Diabetes Genetic Associations Discovered

The largest ever genome-wide association study of those with type 1 diabetes has discovered three new genetic anomalies associated with the disease.

The largest ever genetic analysis of those with type 1 diabetes (T1D) has discovered three new genetic anomalies associated with the disease. The results of the analysis were published in the September edition of PLoS Genetics.

Genome-wide association studies such as this one look at genetic information for large numbers of people with a given condition as well as control subjects to detect genetic variations that can be statistically associated with the condition. Such studies look at single-nucleotide polymorphisms (SNPs), points in the genetic code that commonly vary and frequently indicate the presence of significant genetic mutations.

In the current study, researchers combined genetic data from six large publicly available datasets that included data from 9,934 people with T1D and 16,956 controls. In addition to validating a number of genetic variations previously associated with T1D, the study discovered three new SNPs associated with the condition. The new SNPs are of particular interest because they are in areas of the genome involved in protein-protein interaction, inflammation, and cell signaling activity.

“Our study found SNPs that we had not expected to have any connection to type 1 diabetes,” said lead author Hakon Hakonarson, MD, PhD, director of the Center for Applied Genomics at The Children’s Hospital of Philadelphia, in a press release. “The strongest association among the three SNPs was in the region of the LMO7 gene on chromosome 13. We previously associated another member of the LMO gene family with the childhood cancer neuroblastoma. This gene family plays an important role in protein-protein interactions, but it would not have occurred to anyone that it may be active in type 1 diabetes.”

Further study will be necessary to uncover the actual genetic mutations that may play a role in causing T1D, which researchers hope will lead to the discovery of new treatments for the disease.

Sources

Large Meta-analysis Finds New Genes for Type 1 Diabetes [Press Release]

A Genome-Wide Meta-Analysis of Six Type 1 Diabetes Cohorts Identifies Multiple Associated Loci [PLoS Genetics]

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.